Haoxi Health Technology Limited Class A Ordinary Shares (HAO)vsMeta Platforms Inc. (META)
HAO
Haoxi Health Technology Limited Class A Ordinary Shares
$1.23
+1.65%
COMMUNICATION SERVICES · Cap: $1.97M
META
Meta Platforms Inc.
$593.00
-0.26%
COMMUNICATION SERVICES · Cap: $1.52T
Smart Verdict
WallStSmart Research — data-driven comparison
Meta Platforms Inc. generates 503589% more annual revenue ($214.96B vs $42.68M). META leads profitability with a 32.8% profit margin vs -6.5%. META earns a higher WallStSmart Score of 83/100 (A-).
HAO
Hold49
out of 100
Grade: D+
META
Exceptional Buy83
out of 100
Grade: A-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HAO.
Margin of Safety
+35.2%
Fair Value
$903.82
Current Price
$593.00
$310.82 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 41.2% year-over-year
Earnings expanding 172.7% YoY
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Mega-cap, among the largest globally
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 40.6%
Revenue surging 33.1% year-over-year
Earnings expanding 62.4% YoY
Generating 13.2B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
ROE of -15.5% — below average capital efficiency
Negative free cash flow — burning cash
Currently unprofitable
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : HAO
The strongest argument for HAO centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 41.2% demonstrates continued momentum.
Bull Case : META
The strongest argument for META centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 32.8% and operating margin at 40.6%. Revenue growth of 33.1% demonstrates continued momentum.
Bear Case : HAO
The primary concerns for HAO are Market Cap, Return on Equity, Free Cash Flow.
Bear Case : META
The primary concerns for META are Piotroski F-Score.
Key Dynamics to Monitor
HAO profiles as a hypergrowth stock while META is a growth play — different risk/reward profiles.
META carries more volatility with a beta of 1.24 — expect wider price swings.
HAO is growing revenue faster at 41.2% — sustainability is the question.
META generates stronger free cash flow (13.2B), providing more financial flexibility.
Bottom Line
META scores higher overall (83/100 vs 49/100), backed by strong 32.8% margins and 33.1% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Haoxi Health Technology Limited Class A Ordinary Shares
COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA
Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, focused on revolutionizing healthcare delivery through innovative solutions. Utilizing advanced technologies, including artificial intelligence and data analytics, the company significantly improves diagnostic accuracy, treatment efficiency, and patient management. With a robust commitment to research and development, Haoxi is well-positioned to capitalize on emerging trends in healthcare technology, presenting considerable growth opportunities for institutional investors looking to engage in this dynamic market.
Meta Platforms Inc.
COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA
Meta Platforms, Inc. develops products that enable people to connect and share with friends and family through mobile devices, PCs, virtual reality headsets, wearables and home devices around the world. The company is headquartered in Menlo Park, California.
Visit Website →Compare with Other ADVERTISING AGENCIES Stocks
Want to dig deeper into these stocks?